To amend title XIX of the Social Security Act to require that diagnostic and supplemental breast examinations are furnished without cost sharing under the Medicaid program, and for other purposes.

Summary of HR 8729 (119th Congress)

Purpose and intent

HR 8729 aims to amend title XIX of the Social Security Act (Medicaid) to ensure that diagnostic and supplemental breast examinations are provided without cost sharing (i.e., no copays, coinsurance, or deductibles) under the Medicaid program. The bill signals an emphasis on reducing financial barriers to breast health services as part of Medicaid benefits.

Key provisions and changes

• Elimination of cost sharing for breast examinations: The primary change is that diagnostic breast examinations and supplemental breast examinations would be furnished to Medicaid beneficiaries without cost sharing. This applies to services used to diagnose or further evaluate breast health concerns beyond routine screening.
• Scope of examinations covered: The term “diagnostic and supplemental breast examinations” typically includes procedures and evaluations performed when a breast concern is identified or when additional assessment is needed beyond a standard screening mammogram. The bill would require Medicaid to cover these examinations without charges to the patient.
• Relation to existing Medicaid benefits: The change would be implemented within the existing framework of Medicaid benefits under title XIX. The bill would modify payment and coverage rules to ensure providers cannot bill enrollees for these specific services.
• No explicit broader changes stated: The summary text provided does not indicate additional reforms beyond eliminating cost sharing for the specified breast examinations.

Who would be affected

• Medicaid beneficiaries: Individuals enrolled in federally supported state Medicaid programs would benefit from the removal of cost sharing for diagnostic and supplemental breast examinations.
• Health care providers: Physicians, radiologists, and other clinicians who perform diagnostic and supplementary breast examinations under Medicaid would be affected by the updated coverage requirements, including billing practices to ensure no patient charges for these services.
• State Medicaid programs: States administering Medicaid would need to implement the policy, adjust their fee schedules, and ensure compliance with the no-cost-sharing requirement for these services.

Procedural and timeline aspects

• Introduction and referral: The bill was introduced in the House and referred to the Committee on Energy and Commerce on May 11, 2026.
• Sponsorship: The bill has co-sponsors, including Greg Landsman and Debbie Dingell.
• Next steps in process: As a newly introduced measure, it would proceed through committee consideration, potential amendments, and, if approved, move to the House floor for debate and voting. If enacted, it would require federal guidance and cooperation with state Medicaid programs to implement the no-cost-sharing requirement.

Potential impact and considerations

• Patient access and affordability: By removing cost-sharing for diagnostic and supplemental breast examinations, more patients may pursue timely diagnostic workups, potentially leading to earlier detection and management of breast health issues.
• Budgetary implications: Eliminating cost sharing shifts costs from patients to the Medicaid program; overall budgetary impact would depend on utilization rates and the unit costs of the covered examinations.
• Equity and public health: The measure aligns with efforts to reduce financial barriers to essential health services and could contribute to improved breast cancer detection and follow-up care among low-income populations.

If you’d like, I can compare this bill to existing Medicaid breast examination policies or provide a brief fiscal impact estimate based on typical Medicaid service costs.